It is well established that specific interaction between adhesion molecules of endothelial cells and receptors on leukocytes can separate and recruit leukocytes from the bloodstream to sites of inflammation and coagulation. Previously, we showed that P-selectin can be absorbed onto the surface of a bloodcompatible microrenathane tube, and the P-selectin-coated surface could successfully capture P-selectin receptor-positive stem cells from physiological shear flow in vitro and from the bloodstream in vivo. In this paper, P-selectin was covalently attached to the surface of nanoscale liposomes to create targeting nanoparticles (NPs). Small interfering RNA (siRNA) was encapsulated by these nanoscale liposomes, and the liposomes were stabilized by PEGylation with DSPE-PEG2000. Experiments showed that these P-selectin-, PEGylated-, nanoscale-liposomes (PS-DSPE-PEG NPs) could be absorbed onto the inner surface of microrenathane tubing. The coated surface could specifically capture targeted cells from physiological shear flow, efficiently deliver encapsulated siRNA into adherent cells and dramatically silence the targeted gene neutrophil elastase. With this device, we create a high localized concentration for siRNA delivery in the circulatory system, providing circulating target cells adequate time to interact with therapeutic materials. SiRNA is efficaciously delivered into specific target cells, thereby providing a powerful tool for highly efficient siRNA transfection and other therapeutic materials delivery in circulation. The method should prove especially useful for diseases derived from disorders of blood cells.
Introduction
Silence of genes by small interfering RNA (siRNA) is an evolutionarily conserved biological process. 1, 2 The advantages of siRNAs come from their potential to silence genes in a highly specific and efficacious manner by double-stranded RNA, and to target every gene and every cell that have the necessary machinery. 3, 4 Introduction of synthetic exogenous siRNA into mammalian cells has emerged as a powerful approach for fundamental biological research and gene therapy. [5] [6] [7] After synthetic exogenous siRNA crosses the cellular membrane and enters the cytoplasm where they join the siRNA pathway, they bind to sequence-specific mRNA and induce targeted gene silencing. However, the effects of synthetic siRNA applications are limited by their transfection efficiency. 8 Thus, the successful application of siRNA technology to biological research and potential gene therapies largely depends on the development of delivery vehicles which can highly efficiently and biologically deliver siRNA to targeted cells.
A number of carriers have been developed for siRNA delivery in mammalian cells. Liposomes, a lipid-based vehicle, have long been selected as a carrier for siRNAs and other therapeutical materials. 9 Liposomes are made of similar material to the cellular membrane, 10 and so they have biocompatibility and biodegradability with living cells. They are formed by self-closing with one or more concentric lipid bilayers and an inner aqueous phase, 11 in which siRNAs can be easily encapsulated into the liposome interior and isolated from the surrounding environment. Thus, liposomes not only act as a carrier of siRNA, but also provide a protection for siRNAs within the cell. In the past decade, the properties of liposomes have been broadly manipulated by different lipid formulations and agents, such as proteins, peptides and polymers, to fit the applications of the liposome as a carrier for genes and other therapeutic material delivery. 12 The surface modification of liposomes with PEG confers them with steric protection, which improves their vascular residence time 13 by escaping the reticuloendothelial system. [14] [15] [16] In general, when ligands deliver nanoparticles (NPs) to their targeted cells, it is imperative that the ligands bind with high selectivity to molecules that are uniquely expressed on the cell surface. To maximize specificity and transfection efficiency, the selected ligands or antibodies must have higher affinity to the surface receptor or antigen, which in turn should be overexpressed on targeted cells relative to those on normal cells. In our project, P-selectin, a receptor expressed in endothelial cells and platelets and an adhesion molecule for leukocytes, was selected to construct target-specific liposome NPs. To increase the efficiency of siRNA delivery, liposomal NPs were immobilized onto the surface of a blood-compatible microtube, and the surfaces of siRNA carrier NPs were modified by PEGylation and covalently conjugated with the adhesion molecule P-selectin. This combination was found to be very effective at achieving knockdown of a target gene in circulating cells.
Results

Building target-specific NPs
Small interfering RNA was condensed with protamine and double-stranded calf thymus DNA to enhance its delivery efficiency. 17 The encapsulation of siRNA was achieved by rehydration of a lipid thin film in the presence of condensed siRNA ( Figure 1b) . The siRNA encapsulation efficacies were determined with RiboGreen assay. The intensities of RiboGreen fluorescence were measured with or without Triton X-100, showing an B90% encapsulation efficacy. To construct P-selectin target-specific NPs (PS-DSPE-PEG NP), sulfhydryl (ÀSH) groups were introduced into P-selectin by Traut's Reagent, and then the ÀSH groups of P-selectin were covalently linked to maleimide groups of DSPE-PEG2000 to form a PS-DSPE-PEG complex (Figure 1a ). An insertion step then conjugated PS-DSPE-PEG onto unilamellar liposomes to make targeted NPs (PS-DSPE-PEG NP). To make non-targeted NPs (DSPE-PEG NP), DSPEPEGs were inserted onto unilamellar liposomes without P-selectin (Figure 1b) . The specific targeting activity of NPs was granted by P-selectin, whereas neutralization of the NP surface and stabilization of the particles was achieved by DSPE-PEG2000. Both effects were important for subsequent microtube coating and perfusion experiments. The target specificity of the NPs was provided by the covalently attached P-selectin, an important endothelial cell adhesion molecule, onto the surface of the particles.
The physical characteristics of the NPs are summarized in Table 1 . The particle diameters of Cy3-siRNA Liposome and DSPE-PEG modified non-targeting NPs were similar, whereas PS-DSPE-PEG modified targeting NPs were 35-40 nm larger than non-targeting NPs. The zeta potential was dramatically reduced by DSPE-PEG surface modification compared with those of naked NPs. Attachment of PS-DSPE-PEG onto NPs showed a slight increase of zeta potential compared with that of the NPs modified only by DSPE-PEG, but remained lower than the naked NP zeta potential. It is likely that the sign and magnitude of the zeta potential could be controlled by varying the ratio of PEG and P-selectin on the liposomal surface. Figure 1c contains images of siRNA liposomes taken with scanning electron microscopy, and shows that the liposomes were well formed by rehydration of lipid thin film with a mixture of siRNA, protamine and thymus double-strand DNA. The size of the liposomes was in the Figure 1 Generation of P-selectin receptor-specific nanoparticles (NPs). (a) Traut's Reagent (2-Iminothiolane HCl) reacts with primary amines (ÀNH 2 ) of P-selectin, which introduces sulfhydryl (ÀSH) groups to the protein. The sulfhydryl group of P-selectin reacts with the maleimide group of DSPE-PEG2000 maleimide to form a DSPE-PEG-P-selectin conjugate. R 1 represents P-selectin, R 2 represents DSPE-PEG(2000) maleimide. (b) Multilamellar particles were formed by hydration of lipid thin films with protamine and thymus DNA packaged siRNA and extruded to produce unilamellar NPs (UNPs). P-Selectin-DSPE-PEG or DSPE-PEG were inserted into UNP to form P-selectin receptor-specific NPs or non-targeting NPs, respectively. (c) Scanning electron microscopy of liposomes. Scale bars indicate the micrograph magnifications.
Nanoparticle-based platform for gene knockdown Z Huang and MR King range of 100-150 nm. This indicates that the results from scanning electron microscopy agree well with the liposome dimensions measured by dynamic light scattering (Table 1) . To determine the efficiency of siRNA encapsulation by the liposomes, RiboGreen assay was used to measure the intensities of siRNAs in the presence or absence of Triton X-100, showing about 90% of total siRNA was encapsulated by the liposomes.
P-selectin is necessary for PS-DSPE-PEG NP absorption onto the surface of microtubing
Our previous results have shown that the recombinant human P-selectin/Fc chimera (rhP/Fc) can be absorbed onto the interior surface of blood-compatible microrenathane tubing, and the coated microtube could capture and purify cells expressing the P-selectin receptor, such as hematopoietic stem and progenitor cells from flow. 18, 19 To test whether PS-DSPE-PEG NPs could attach onto the surface of microtubing, the PS-DSPE-PEG NPs were loaded into the microtube and incubated for 2 h at room temperature (RT). After perfusion, NPs without P-selectin modification were not retained in microtubes precoated with rhP/Fc (Figures 2a and b) , whereas NPs coated with P-selectin could coat onto the surface of the microtube and resist elution under shear stress (Figures 2c and d) . These results indicate that P-selectin covalently attached onto the surface of NPs was indispensable for absorption of the NPs onto the surface of the microtube (Figure 2 ).
Cellular uptake and knockdown efficiencies for different NPs under static conditions
To investigate the delivery efficiency of different NPs, we conducted a cellular uptake study using Cy3-labeled siRNA. The fluorescence intensities of the cell lysates were used to measure the siRNA cellular delivery efficiencies by different lipid vesicles. The lysate from cells treated with naked Cy3-siRNA showed a slightly higher fluorescence intensity than those from untreated cells, whereas the Cy3-siRNA encapsulated by liposomes (Cy3-siRNA Liposome) showed a significant (Po0.01) increase in fluorescence intensity (Figure 3a ). For comparison, attachment of DSPE-PEG-2000 maleimide to the particles (DSPE-PEG NP) reduced the siRNA delivery efficiency dramatically ( Figure 3a ). Fluorescence intensity of cells treated with PS-DSPE-PEG NP showed 2.3-fold higher loading than cells treated with naked NPs and 9.2-fold higher than cells treated with non-targeting NPs (Figure 3a ), which indicates that P-selectin significantly (Po0.01) increased the Cy3-siRNA delivery efficacy to HL60 cells. The low siRNA delivery efficiency observed with PEGylated NPs is most likely due to the PEGylation providing a steric hindrance for close contact between the cell and NP surfaces. The higher delivery efficiency for PS-DSPE-PEG NPs might be the result of specific receptor-ligand interaction, 20, 21 which could facilitate the cellular internalization of the particles.
To test the relationship between siRNA uptake and gene knockdown efficiencies, siRNAs of neutrophil elastase (ELA2), a specific gene expressed in neutrophils, were delivered in naked or encapsulated form in different lipid vesicle formulations. The total RNA was Figure 3b ).
PSGL-1-mediated uptake of PS-DSPE-PEG NPs
It has been shown that the major receptor of P-selectin in leukocytes is PSGL-1. 22 For reference, PSGL-1 expression on undifferentiated HL-60 cells is about 24% below human neutrophils, or 12 000 copies per cell. 18, 23, 24 To assess the specificity of PS-DSPE-PEG NPs, several strategies were applied to test the interaction of the particles and HL60 cells which are known to express PSGL-1. When NPs were coated with IgG instead of P-selectin, uptake study showed that siRNA delivery efficiency was not notably higher than that of nontargeted NPs, and significantly (Po0.01) lower than that of PS-DSPE-PEG NPs. PSGL-1 receptors in HL60 cells were pre-blocked with anti-PSGL-1 antibody or PS-DSPE-PEG NPs were pre-blocked with anti-P-selectin antibody, and then the uptake experiments repeated. Both showed a dramatic decrease of the uptake efficiencies compared with the non-blocked samples ( Figure 4a ). rq-PCR were used to confirm the specificity of PS-DSPE-PEG NPs. No obvious ELA2 silencing was observed in the cells from IgG-attached NPs, nor in cells pre-incubated with anti-PSGL-1 or from the PS-DSPE-PEG NPs pre-incubated with anti-P-selectin in rq-PCR (Figure 4b ). However, HL60 cells transfected with PS-DSPE-PEG NPs showed a dramatic knockdown in the mRNA level of ELA2 compared with those of the non-targeting NP group, IgG NP, HL60 pre-incubated with anti-PSGL-1 and PS-DSPE-PEG NP pre-incubated with anti-P-selectin groups in rq-PCR ( Figure 4b ). These data support the notion that interaction of P-selectin and PSGL-1 is necessary for PS-DSPE-PEG NP binding and the delivery of siRNA into HL60 cells.
HL60 cells captured from flow
As shown in Figure 2 , PS-DSPE-PEG NPs were effectively immobilized on the inner surface of microtubes. On the basis of our previous results, 25 we expected that 26 After cellular perfusion, a near monolayer of HL60 cells was tethered (Figure 5d ) and accompanied by a thin layer of PS-DSPE-PEG NPs absorbed onto the inner surface of the microtube (Figure 5c ). Furthermore, the coated PS-DSPE-PEG NPs were released with the tethered cells by higher shear stress and air embolism from the microtube surface (Figures 5e and f) . This indicates that the affinity of PS-DSPE-PEG NPs to HL60 was greater than the NP affinity for the microtube surface.
To verify that PSGL-1 is necessary for the capture of HL60 cells by PS-DSPE-PEG NPs under flow, we preincubated HL60 cells with anti-PSGL-1 for 1 h at RT and then perfused these cells over the PS-DSPE-PEG-NP surface. Alternatively, MCF7 cells, a breast cancer cell line that has been demonstrated to not interact with Pselectin, 27 were perfused over the surface of PS-DSPE-PEG NP-coated microtubes. Both of the perfusions showed negligible capture of cells onto the PS-DSPE-PEG-NP surfaces (Figures 5j and l) , which further confirm that PSGL-1 is indispensable for tethering and capturing the cells onto the PS-DSPE-PEG-NP surface. The requirement of P-selectin 27 for PS-DSPE-PEG-NP surface capture of HL60 cells was demonstrated by using anti-P-selectin antibody to block P-selectin on PS-DSPE-PEG NPs, and using a nonspecific IgG to replace P-selectin to construct IgG NPs. Both IgG NPs and PS-DSPE-PEG NPs blocked by anti-P-selectin antibody were shown to successfully coat onto the surface of microtubes (Figures 5m and o) . However, neither the PS-DSPE-PEG NPs that were pre-blocked by anti-P-selectin antibody nor the IgG-substituted particles had the ability to immobilize HL60 cells onto the coating surfaces (Figures 5n and p) .
To measure the siRNA delivery efficiency of PS-DSPE-PEG NPs under perfusion condition in microtubes, HL60 cells were infused into microtubes that were coated with Cy3-siRNA encapsulated in PS-DSPE-PEG NPs or precoated with P-selectin and then Cy3-RNAs encapsulated by DSPE-PEG NPs. Cy3-siRNA encapsulated by PS-DSPE-PEG NPs were efficiently bound and delivered into HL60 cells (Figures 5t-v) . The surface of microtubes pre-coated with P-selectin and then with Cy3-siRNA-DSPE-PEG NPs could capture cells from flow (data not shown), but almost none of the Cy3-siRNA was delivered into the cells due to Cy3-siRNAs-encapsulated NPs that were eluted out of the microtube during the perfusion (Figures 5q-s) . In tubes coated with IgG NPs, the absorption of the NPs onto the surface of the microtube was quite effective; however, the number of cells tethered onto the IgG NP surface was negligible (data not shown). To test the real-time uptake of the siRNA into the target cells by PS-NPs, a time course study (1, 2, 4, 6 and 8 h) for PS-NP delivery of siRNA into HL60 cells during rolling was conducted. The results showed that the peak in cellular uptake of PS-DSPE-PEG NP -Cy3-siRNA was reached after 2 h of rolling (data not shown).
Taken together, these data suggest that the capture of HL60 cells by PS-DSPE-PEG NPs is mediated by adhesion molecules rather than nonspecific binding, and the interaction of P-selectin with PSGL-1 is crucial for capturing and delivering siRNA into the specific target cells. ELA2 knockdown by ELA2-siRNA-PS-DSPE-PEG NPs was also measured at the protein level by immunoblot analysis. After the cells were perfused over ELA2-siRNA-PS-DSPE-PEG NPs and cultured for 84 h, all three sets of ELA2 siRNA showed reduction of ELA2 gene translational levels (Figure 6b , upper panel) compared with the control. The same blots were stripped and reprobed with an antibody against GAPDH (glyceraldehyde-3-phosphate dehydrogenase), which verified the same amounts of the protein loaded into each lane of the western blots (Figure 6b lower panel) . ELA2 activity assay was used to further confirm the knockdown of ELA2 by perfusion of cells on the surface of ELA2-siRNA-PS-DSPE-PEG NPs. As shown in Figure 6c , OD reading showed a corresponding reduction of ELA2 activity in activity assays and protein level decrease in western blot analysis.
ELA2 siRNA-PS-DSPE-PEG
To compare the siRNA knockdown efficacies between the static and perfusion conditions, total RNA was extracted from the cells transfected with ELA2 siRNAencapsulated PS-DSPE-PEG NPs under both conditions and reverse transcribed into cDNAs. The resulting cDNAs were used to conduct rq-PCR. Compared with controls, rq-PCR showed that mRNA levels of ELA2 were significantly (Po0.01) decreased by 51 and 74% under static and perfusion conditions, respectively (Figure 6d ). These data also indicate that rolling of cells over an ELA2-siRNA-PS-DSPE-PEG-NP surface resulted in significantly (Po0.05) higher mRNA knockdown efficiency compared with cells transfected under static conditions by ELA2-siRNA-PS-DSPE-PEG NPs (Figure 6d ).
Delivery of siRNA into granulocytes by PS-DSPE-PEG-NP surfaces under perfusion conditions
It is well established that HL60 cells can be induced into a granulocytic phenotype by dimethylsulfoxide. 28 To test if granulocytes could be immobilized, siRNA delivered, and targeted gene silenced by a neutrophil elastase 2 siRNA PS-DSPE-PEG-NP surface, differentiated HL60 cells were perfused over a surface of control Cy3-siRNA or neutrophil elastase 2 siRNA-encapsulated Nanoparticle-based platform for gene knockdown Z Huang and MR King Figure 5 P-selectin and its receptor are necessary for nanoparticles (NPs) to absorb onto the surface of microtube and interact with HL60 cells. P-selectin NPs were coated onto the surface of microrenathane tubing for 2 h at room temperature (RT), and then perfusion experiments conducted. (a) and (b) were taken before perfusion, (c) and (d) were taken after perfusion but before the cells were released. (e) and (f) were taken after the adherent cells were released from the microtubing. In (g) and (h), HL60 cells were perfused through the P-selectin-coated tube. In (i) and (j), cells were pre-incubated with anti-PSGL-1 for 1 h at RT and then perfused through the P-selectin coated tube. In (k) and (l), the perfused cells were MCF7. In (m) and (n), the P-selectin NPs were incubated with anti-P-selectin for 1 h at RT and then applied to the microtube coating. In (o) and (p), P-selectin was replaced with IgG to construct the coating NPs. The pictures were taken after cellular perfusion but before the cells were released from the surface. NPs alone could not (q, r and s) but P-selectin NPs could (t, u and v) deliver Cy3-siRNA into HL60 cells under rolling conditions in the microtubing. q and t were taken in epifluorescence mode, r and u were taken in brightfield mode, and s and v are the merge of q and r, and s and t, respectively. TRITC represents tetramethyl rhodamine iso-thiocyanate filter. Compared with control, rq-PCR showed a significant (Po0.01) (71%) knockdown efficiency for ELA2 mRNA level in granulocytes (Figure 7f ). The images of western blot showed a similar knockdown pattern as rq-PCR (Figure 7g ). The results of rq-PCR are normalized with GAPDH, and western blot also used GAPDH as loading control (Figure 7g ). These results indicate that the PS-DSPE-PEG NP-coated surface has the ability to capture granulocytes from flow and deliver siRNA from the particles into the cells.
Discussion
Mimetics of the physiological process of leukocyte recruitment to the walls of blood vessels have been successfully applied to roll, tether and capture-specific target cells on the surface of microfluidic channels by coating the surface of the channel with endothelial cell adhesion molecules. 29 To silence genes in circulating cells, an implantable device for siRNA delivery was developed in this study. On the basis of our previous results, 18, 19, 25, 30 P-selectin, an adhesion molecule generated in endothelial and platelet cells and involved in the capture of leukocytes from the bloodstream, 22, 31 was selected to construct liposome-based targeted NPs for siRNA delivery. This surface modification endowed the NPs not only with target specificity but also with the ability to adhere onto the inner surface of microtubes. PEG was also used to enhance the stability of this siRNA carrier nanoscale liposome. In addition to particle * * * * * * (Table 1) . Stabilization enhanced the ability of the particles to resist elution under shear stress, and provided sustained protection for the encapsulated siRNA during perfusion and cell culture. Charge neutralization removed the nonspecific interaction between the positive charge of the particles and negative charge of the cellular membrane. Therefore, PEGylation of the particles is important for stability under flow and target specificity. Consistent with our previous reports, 19, 25 large numbers of cells were captured from flow by the PS-DSPE-PEG-NP surface. Although P-selectin-based cell capture is also associated with inflammation of the liver or lung in vivo, our previous work in rats has shown that the risk of systemic inflammatory conditions will be minimal due to the lack of inflammatory chemokines and b-2 integrin ligands on the device surface. 19 More importantly, the coated PS-DSPE-PEG NPs were released with the collection of adherent cells, suggesting that the NPs were tightly bound onto the surface of the cells (Figures  5a-f) . By replacement of P-selectin with an IgG to modify the surface of the NPs, the adhesive function of IgG-NPs to the surface of the microtube was equal to that of PS-DSPE-PEG NPs (Figures 5a-p) . Therefore, the applications of the device can be broadened by antibodies directed against specific surface antigens. Blocking P-selectin by pre-incubation of PS-DSPE-PEG NPs with anti-P-selectin, or PSGL-1 by pre-incubation of HL60 cells with anti-PSGL-1 nearly abolished the binding activity of HL60 cells with the PS-DSPE-PEG-NP surface (Figures 5i, j, m and n), indicating that P-selectin on PS-DSPE-PEG NPs and PSGL-1 on HL60 cells are necessary for the adhesion of HL60 cells. Using MCF7, 27 a cell line without expression of P-selectin receptor, and IgG to replace P-selectin in the construction Figure 7 Differentiated HL60 cells can be transfected, and ELA2 gene can be silenced under rolling conditions by siRNA-PS-DSPE-PEG NPs. HL60 cells were induced into granulocytes by dimethylsulfoxide. After differentiation, the cells were perfused through the tube coated with PS-DSPE-PEG NPs. The picture (a) and (b) were taken after cell perfusion but before the cells were released from the tubes. The pictures of (c) and (d) were taken after the adherent cells were collected from the tubes and cultured for 36 h. The levels of gene knockdown are shown by real-time quantitative-PCR (f) and western blot (g).
Nanoparticle-based platform for gene knockdown Z Huang and MR King of NPs, the cellular perfusion study confirmed that Pselectin on PS-DSPE-PEG NPs and PSGL-1 on the circulating cells were both required for the cell rolling, tethering and capture by the PS-DSPE-PEG-NP surface (Figures 5k, l, o and p) . Furthermore, cells failed to bind to the nonspecific IgG-NP surface, indicating that the binding of PS-DSPE-PEG NPs to Fc receptors was minimal (Figure 5p ). Taken together, these results indicate that the cell capture from shear flow by the PS-DSPE-PEG NP-coated device was due to the interaction of adhesion molecules with their cellular receptor, rather than due to nonspecific binding of the cells to lipids, Fc receptors or the microrenathane surface. Interestingly, a lack of correlation between vesicle uptake and mRNA knockdown efficiencies was observed in naked NPs and target-specific PS-DSPE-PEG NPs. Target-specific PS-DSPE-PEG NPs provided 2.3-fold higher siRNA delivery efficiency than that of naked NPs, and showed a 3.7-fold higher gene silencing activity than that of naked NPs. The explanation for this might be that target-specific PS-DSPE-PEG NPs deliver their encapsulated cargo through a receptor-mediated pathway, which not only has relatively higher affinity but also greater efficiency with its receptor recycling/trafficking mechanism. 32 On the other hand, non-targeting naked NPs deliver their cargo by a nonspecific charge-charge interaction.
Clearly, the efficiency of the particle internalization through receptor-ligand interaction was greater than that for charge-charge in our case. Another advantage of the device is that PS-DSPE-PEG NPs were coated onto the surface of a microtube and would not be introduced into the circulation to distribute into the organs and tissues, such as reticular connective tissue, lymph nodes, spleen and liver, thus partially avoiding the effect of the reticuloendothelial system. 33, 34 It is reasonable to expect that the immobilized PS-DSPE-PEG NPs on the surface of the microtube have relatively longer half-life than those in the circulation. Therefore, compared with particles introduced into the circulation, a lower dose of PS-DSPE-PEG NPs in the device could be used to achieve the same effect of gene silencing.
The knockdown efficiency for cells perfused over the PS-DSPE-PEG-NP surface was higher than that of the equivalent static condition (Figure 6d ). When the cells were perfused over the PS-DSPE-PEG-NP surface in the microtube, the interaction of the cells with PS-DSPE-PEG NPs resulted in cell tethering, rolling and adhesion on the surface of PS-DSPE-PEG NPs. In particular, when the cells were rolling on the surface of the particles, the whole cellular membrane has opportunity to contact and interact with the PS-DSPE-PEG NPs. In this manner the rolling cells could pick up more PS-DSPE-PEG particles than cells resting static on the surface. In addition, it is well known that shear stress tends to flatten rolling cells, thereby increasing the instantaneous contact area with an adhesive surface. Finally, the repeated microscale cell deformations, which occur during rolling adhesion may enhance the intracellular transport and mixing of siRNA, although this remains to be directly demonstrated.
In summary, we have developed an siRNA delivery device that can successfully capture targeted cells from physiological shear flow, and efficiently deliver siRNA into targeted cells and silence a gene of interest. Most importantly, this device could be incorporated into the circulatory system in vivo and modify targeted cells in the bloodstream. 19 This indicates that PS-DSPE-PEG-NP surfaces could capture nucleated cells from the blood stream and deliver contents of the particles into the captured cells. We believe that this device has great potential to increase the efficacy of therapeutic material delivery, reduce side effects and enhance therapies directed at circulating cells in vivo.
Materials and methods
Cell lines and culture HL60 and MCF7 cell lines were purchased from American Type Culture Collection (ATCC, Manassas, VA, USA), and maintained in RPMI 1640 and Dulbecco's modified Eagle's medium (Gibco-Invitrogen, Carlsbad, CA, USA), respectively, and supplemented with 100 IU ml À1 penicillin, 10 mg ml À1 streptomycin and 10% heat-inactivated fetal bovine serum in 5% CO 2 at 37 1C. The dimethylsulfoxide-induced differentiation of HL-60 cells into granulocytes was as previously described. 35 The induction was conducted by adding 1.5% (v/v) dimethyl sulfoxide (Sigma-Aldrich, St Louis, MO, USA) into the growth medium for 7 days. The medium was changed every 2 days.
Preparation of siRNAs
The human neutrophil elastase siRNAs were from Invitrogen (Carlsbad, CA, USA). The negative control and Cy3-negative control siRNAs were purchased from Integrated DNA Technologies (Coralville, IA, USA). The siRNAs purchased from Integrated DNA Technologies were annealed according to the manufacturer's instructions. Human neutrophil elastase siRNA sequences were as follows:
Neutrophil elastase set no. The sequences of Cy3-negative control siRNAs and the sequences of the unlabeled negative control were the same, and are as follows:
The condensation of siRNAs were prepared by mixture of 50 ml of 50 mM siRNAs with 20 ml of 2 mg ml À1 protamine, 16 ml of 2 mg ml À1 of double-strand calf thymus DNA (Sigma-Aldrich) and DNA RNAase nuclease-free water (Gibco-Invitrogen) up to 200 ml, followed by incubation at RT for 10-15 min.
Nanoparticle-based platform for gene knockdown Z Huang and MR King siRNA-liposome preparation Multilamellar liposomes, composed of 1,2-Dioleoyl-3-Trimethylammonium-Propane (DOTAP), 1,2-Dipalmitoyl-sn-Glycero-3-Phosphocholine (DPPC) and cholesterol (Chol) (Avanti Polar Lipids, Alabaster, AL, USA) at molar ratios of 0.5:1.75:1.75 (DOTAP/DPP/Chol), were prepared by a thin lipid film method. 36 Briefly, a total of 380 nM of lipids were dissolved in chloroform in a glass tube and gently dried under nitrogen and further evaporated to dryness under vacuum. The lipid film was hydrated with a swelling solution composed of protamine and thymus double-strand DNA-condensed siRNA (2.5 nmol) dissolved in DNA and RNAase nuclease-free water to create multilamellar liposomes at a total lipid concentration of 1.9 mM. The resulting multilamellar liposomes were sized by repeated thawing and freezing, and then subjected to extrusion (Avanti Polar Lipids) through polycarbonate membranes (Nucleopore, Whatman, NJ, USA) with gradually decreasing pore size (0.4, 0.2 and 0.1 mm) to produce unilamellar nanoscale liposomes with 30 cycles each at 50 1C (Figure 1b) . The efficiency of siRNA entrapment was determined by a Quant-iT RiboGreen RNA assay (Molecular Probes, Invitrogen, Eugene, OR, USA) according to the manufacturer's instruction. The intensity of siRNA encapsulated within liposomes was measured in the presence or absence of Triton X-100 at wavelengths of excitation 480 nm and emission 520 nm. The NPs were freshly prepared and diluted with phosphate-buffered saline (PBS), and the mean particle diameter and surface charge (zeta potential) measured by dynamic light scattering and Malvern Zetasizer nano ZS (Malvern Instruments Ltd., Worcestershire, UK), according to the manufacturers' protocols. The shapes and sizes of the unilamellar nanoscale liposomes were also observed by scanning electron microscopy. Samples were rapidly frozen in liquid propane and immediately transferred to 1% osmium acetone (À196 1C). Samples were freeze-substituted over 4 days. Scanning electron microcopy samples were then critical point dried, mounted and then sputter coated. Images were taken on a Hitachi S900 (Hitachi, Tokyo, Japan).
Cellular uptake study HL60 cells (1.5 Â 10 5 cells per 0.5 ml well) were cultured in 24-well plates (Corning Inc., Corning, NY, USA) for 20 h. Cells were treated with naked Cy3-siRNA and different Cy3-siRNA NPs in the culture medium at 37 1C and 5% CO 2 for 4 h. Cells were harvested by centrifugation and washed three times with PBS followed by incubation in 300 ml lysis buffer (1% Triton X-100 in PBS) at 4 1C while vortexing for 30 min. Fluorescence intensity of 200 ml of cell lysate was measured by a SpectraMax M2/M2e Microplate Reader (Molecular Device, Sunnyvale, CA, USA) at wavelengths of excitation 550 nm and emission 570 nm.
Preparation of target-specific and stabilized NPs
Recombinant human P-selectin/Fc chimera (rhP/Fc) (R&D Systems, Minneapolis, MN, USA) was dissolved in PBS and centrifuged with Microcon YM-30 30 kDa molecular weight cutoff filters (Millipore; Billerica, MA, USA) to concentrate and remove salt from the protein.
The resulting rhP/Fc was incubated with Traut's reagent (Pierce, Rockford, IL, USA) in PBS at RT for 1.5 h to introduce sulfhydryl (ÀSH) groups into the proteins (Figure 1a) . The molar ratio of rhP/Fc to Traut's Reagent was 1:7.5. The excess Traut's reagent was removed with a YM-30 column. The coupling reaction was carried out by mixing NHS-activated rhP/Fc with 1,2-distearoyl-snglycero-3-phosphoethanolamine-N-maleimide 2000 (DSPE-PEG2000 maleimide) (Avanti Polar Lipids) at 4 1C overnight (Figure 1a) . The molar ratio of rhP/Fc to DSPE-PEG2000 maleimide was 1:3. The non-immune stimulated IgG1 (BD Pharmingen, Franklin Lakes, NJ, USA) as isotype-matched negative control was used to construct IgG-DSPE-PEG2000 maleimides as the procedure of rhP/ Fc-DSPE-PEG2000 maleimide described above. Non-targeting and targeting NPs were generated by incubating the mixture of 5 ml unilamellar nanoscale liposome suspension with 15 ml micelle solution of DSPE-PEG2000 maleimide, IgG-DSPE-PEG2000 maleimides or rhP/Fc-DSPE-PEG2000 maleimide, respectively, at 50 1C for 15 min, and then cooled down at RT. The molar ratio of total lipid to DSPE-PEG2000 maleimide was 19:1 ( Figure 1b) .
Microtube surface preparation
For experiments with P-selectin targeting NPs, 20 ml of NP solution was diluted with 130 ml of PBS and then perfused into blood-compatible microrenathane tubing (300 mm ID; Braintree Scientific, Braintree, MA, USA), and incubated for 2 h at RT under sterile conditions. For non-targeting NPs, microtubing was pre-incubated with rhP/Fc at 60 mg ml À1 concentration in PBS for 2 h. The non-absorbed rhP/Fc was removed by a gentle PBS wash, and then coated with non-targeting NPs at the same concentration as P-selectin-targeting NPs for 2 h at RT. The nonspecific blocking of the lumen surface was achieved by 1 h incubation with 5% bovine serum albumin (Sigma-Aldrich) dissolved in PBS. Following a gentle PBS wash, the absorbed P-selectin was activated in calcium-enriched Hank's balanced salt solution (2 mmol l À1 Ca ++ ) (HBSS, Gibco, Invitrogen, Carlsbad, CA, USA) for 1 h at RT. 18 
Cell capture and collection
Cell capture and collection experiments were performed as described previously. 18 After surface coating, microtubes were positioned on an inverted epifluorescence microscope (IX-81; Olympus USA, New York, NY, USA) coupled to a CCD camera (Hitachi) for direct visualization of the adherent cells within the tube lumen. 2 Â 10 6 /ml of HL60 or differentiated HL60 cells in HBSS enriched with calcium and 5% bovine serum albumin were incubated at RT for 30 min and then perfused through the tube at a rate of 16 ml min À1 (wall shear stress 1 dyn cm À2 ) for 30 min and then at a rate of 32 ml min À1 (wall shear stress 2 dyn cm À2 ) for another 30 min, and then the adherent cells in the tubes were washed with HBSS enriched with calcium at a rate of 32 ml min À1 (wall shear stress 2 dyn cm
À2
) for 20 min and another 20 min at a rate of 48 ml min À1 (wall shear stress 3 dyncm
) using a motorized syringe pump system. The elusion of adherent cells was performed using a combination of high shear (flow rate 160 ml min
À1
) and air embolism. The collected cells were cultured in 24-well dishes with 500 ml of growth medium. The transfection efficiencies were quantified by epifluorescence microscopy (Olympus IX81, Olympus America Inc., Center Valley, PA, USA) after 36 h of culture.
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